Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited scores highest on Nitro (98) and lowest on Torque (12). Its PosiPenta is 50.61 out of 100, around the middle of similar companies.
On the Penta Grid this week, Takeda Pharmaceutical Company Limited is Grid #26 of 49 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | 50.61 | 31 | 48 | 98 | 12 | 64 |
| Daiichi Sankyo Company, Limited | 43.03 | 30 | 46 | 14 | 70 | 54 |
| Shionogi & Co., Ltd. | 57.69 | 70 | 44 | 42 | 69 | 63 |
| Sumitomo Pharma Co., Ltd. | 47.41 | 62 | 32 | 22 | 76 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -60.26 |
| P/B ratio | 1.34 |
EEarnings
| Trailing EPS | ₹-63.88 |
| Forward EPS | ₹84.99 |
NNitro
| Price | 3849.51 |
| 52-week high | 3934.87 |
| 52-week low | 2483.21 |
| Fall from 52-week high | 2.2% |
TTorque
| Return on equity (ROE) | -2.26% |
| Debt-to-equity | 0.73 |
AAnchor
| Beta (price swings) | 0.10 |
| Market cap | ₹6,14,877 Cr |
| Insider holding | 0.10% |
| Dividend yield | 3.19% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Takeda Pharmaceutical Company Limited's PosiPenta score?
Takeda Pharmaceutical Company Limited's PosiPenta is 50.61 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Takeda Pharmaceutical Company Limited stand on the Penta Grid?
On the Penta Grid this week, Takeda Pharmaceutical Company Limited is Grid #26 of 49 in Japan.
Which PosiPenta pillar is strongest for Takeda Pharmaceutical Company Limited?
Nitro (momentum), with a score of 98 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Takeda Pharmaceutical Company Limited?
Torque (durability), with a score of 12 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.